🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

11 recruiting trials

for Relapsed/Refractory Ovarian Carcinoma

MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer NCT06483048Phase 11 site📍 Scottsdale Mayo Clinic · Tests: Autologous MUC1-activated T-cells, Bendamustine, Biospecimen Collection, Computed Tomography, Cyclophosphamide A Study of PHST001 in Advanced Solid Tumors NCT06840886Phase 120 sites📍 Beverly Hills📍 Los Angeles📍 Palo Alto Pheast Therapeutics · Tests: PHST001, Paclitaxel, Topotecan, Doxorubicin, FOLFIRI Study of NTB-928 in R/R OC NCT07690189Phase 14 sites📍 Birmingham📍 Omaha📍 Lake Success TeneoSeven, Inc. · Tests: NTB-928 Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer NCT04921527Phase 31 site📍 Shanghai Chipscreen Biosciences, Ltd. · Tests: chiauranib, Placebo, Paclitaxel Evaluation of XYA02 in Patients With Advanced Solid Tumors NCT07670312Phase 1, Phase 25 sites📍 Sydney📍 Sydney📍 Melbourne XYone Therapeutics, Inc · Tests: XYA02 Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer NCT05983276Phase 21 site📍 Maywood Loyola University · Tests: Decitabine, Carboplatin, Paclitaxel, Selinexor A Phase 3 Study of Manganese-primed Immunochemotherapy in Patients With Advanced Ovarian Cancer NCT07822646Phase 36 sites📍 Beijing📍 Beijing📍 Beijing Chinese PLA General Hospital · Tests: Manganese Chloride, Nab-paclitaxel, Platinum chemotherapy, Anti-PD-1 antibody, Placebo 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors NCT07189871Phase 1, Phase 25 sites📍 Dothan📍 Grand Rapids📍 Omaha Radiopharm Theranostics, Ltd · Tests: 177Lu-BetaBart, BetaBart + unlabeled BetaBart A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas NCT06999187Phase 110 sites📍 Denver📍 Orlando📍 Sarasota Dren Bio · Tests: DR-0202 A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours) NCT07306559Phase 113 sites📍 Los Angeles📍 Indianapolis📍 Houston Boehringer Ingelheim · Tests: BI 3820768 Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors NCT07410494Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EB-SELECT Single-Target CAR-NK Cells, Dual-Target Antigen-Selected CAR-NK
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy